-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Silexion Therapeutics Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2023 to Q4 2024.
- Silexion Therapeutics Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2024 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)